Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 PatientsFrancesca Minoia, Angelo Ravelli, Sergio Davì et al.|Arthritis & Rheumatology|2014Cited by 430
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort studyAlessandro Consolaro, Rita Consolini, Daniel J. Lovell et al.|The Lancet Child & Adolescent Health|2019Cited by 214
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritisFrancesca Minoia, Angelo Ravelli, Francesca Bovis et al.|Annals of the Rheumatic Diseases|2019Cited by 109
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanerceptAngelo Ravelli, Sara Verazza, Sergio Davì et al.|Pediatric Rheumatology|2016Cited by 41
Development and Testing of a Hybrid Measure of Muscle Strength in Juvenile Dermatomyositis for Use in Routine CareGiulia Varnier, Angelo Ravelli, Silvia Rosina et al.|Arthritis Care & Research|2017Cited by 25